Hierarchical Clustering and Schur Complement for Automatic Hyperspectral Band Selection
ModellingBand selection is a crucial step in hyperspectral imaging to reduce spectral redundancy and processing costs whilst retaining information useful for classification. Most existing approaches require the number of bands to be retained to be set manually or
Valérie N’Guessan Gboulouhonon Komenan N’dri +3 more
doaj +1 more source
Molecular Oncology, EarlyView.Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Band Selection via Band Density Prominence Clustering for Hyperspectral Image Classification
Remote SensingBand clustering has been widely used for hyperspectral band selection (BS). However, selecting an appropriate band to represent a band cluster is a key issue.
Chein-I Chang +2 more
doaj +1 more source
Unsupervised Hyperspectral Band Selection via Multimodal Evolutionary Algorithm and Subspace Decomposition. [PDF]
Sensors (Basel), 2023 Wei Y, Hu H, Xu H, Mao X.
europepmc +1 more source
Molecular Oncology, EarlyView.LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Hyperspectral Characteristic Band Selection and Estimation Content of Soil Petroleum Hydrocarbon Based on GARF-PLSR. [PDF]
J Imaging, 2023 Shi P, Jiang Q, Li Z.
europepmc +1 more source
CEACAM1 participation in breast cancer progression
Molecular Oncology, EarlyView.In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Joint Learning of Correlation-Constrained Fuzzy Clustering and Discriminative Non-Negative Representation for Hyperspectral Band Selection. [PDF]
Sensors (Basel), 2023 Li Z, Wang W.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Molecular Oncology, EarlyView.Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Band selection for oxygenation estimation with multispectral/hyperspectral imaging. [PDF]
Biomed Opt Express, 2022 Ayala L +6 more
europepmc +1 more source